BDBM202425 US9238644, 31

SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2ccc(nc2)[N+]#[C-])ncc1Cl

InChI Key InChIKey=TUVMYGJFJFCRAS-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 202425   

TargetVascular endothelial growth factor receptor 3(Human)
Cancer Therapeutics Crc Pty

US Patent
LigandPNGBDBM202425(US9238644, 31)
Affinity DataIC50: 48nMpH: 7.4Assay Description:A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent